Overview Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers Status: Completed Trial end date: 2013-11-30 Target enrollment: Participant gender: Summary This study will assess the safety, tolerability, and pharmacokinetics (PK) of orally administered ALS-008176 in healthy volunteers. Phase: Phase 1 Details Lead Sponsor: Alios Biopharma Inc.